Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stuart-Harris

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Cancer Treatment Reports|February 1, 1986
Cytarabine: an inactive drug for extensive-stage small cell lung cancerR Stuart-Harris, J Bishop, D Raghavan, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1987
Patient treatment preference in advanced breast cancer: a randomized cross-over study of doxorubicin and mitozantroneR Stuart-Harris, R J Simes, A S Coates, et al.
Lancet (London, England)|January 19, 1985
Low-dose aminoglutethimide and aromatase inhibitionM Dowsett, S L Jeffcoate, S Santner, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1986
Extraskeletal Ewing's sarcoma: a clinical, morphological and ultrastructural analysis of five cases with a review of the literatureR Stuart-Harris, E J Wills, J Philips, et al.
Breast (Edinburgh, Scotland)|November 25, 2010
Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohortK R Beckmann, J Buckingham, P Craft, et al.
Seminars in Oncology|February 1, 1992
Carboplatin-containing regimens for small cell lung cancer: implications for management in the elderlyD Raghavan, J F Bishop, R Stuart-Harris, et al.
Gynecologic Oncology|November 3, 2006
Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel--ANZGOG 02-01A V Tinker, V Gebski, B Fitzharris, et al.
Clinical Endocrinology|February 1, 1985
Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancerR Stuart-Harris, M Dowsett, A D'Souza, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 14, 2012
Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behavioursB Thewes, P Butow, M L Bell, et al.
British Journal of Cancer|October 1, 1985
A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patientsM Dowsett, A L Harris, R Stuart-Harris, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Cancer Treatment Reports|February 1, 1986
Cytarabine: an inactive drug for extensive-stage small cell lung cancerR Stuart-Harris, J Bishop, D Raghavan, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1987
Patient treatment preference in advanced breast cancer: a randomized cross-over study of doxorubicin and mitozantroneR Stuart-Harris, R J Simes, A S Coates, et al.
Lancet (London, England)|January 19, 1985
Low-dose aminoglutethimide and aromatase inhibitionM Dowsett, S L Jeffcoate, S Santner, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1986
Extraskeletal Ewing's sarcoma: a clinical, morphological and ultrastructural analysis of five cases with a review of the literatureR Stuart-Harris, E J Wills, J Philips, et al.
Breast (Edinburgh, Scotland)|November 25, 2010
Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohortK R Beckmann, J Buckingham, P Craft, et al.
Seminars in Oncology|February 1, 1992
Carboplatin-containing regimens for small cell lung cancer: implications for management in the elderlyD Raghavan, J F Bishop, R Stuart-Harris, et al.
Gynecologic Oncology|November 3, 2006
Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel--ANZGOG 02-01A V Tinker, V Gebski, B Fitzharris, et al.
Clinical Endocrinology|February 1, 1985
Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancerR Stuart-Harris, M Dowsett, A D'Souza, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 14, 2012
Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behavioursB Thewes, P Butow, M L Bell, et al.
British Journal of Cancer|October 1, 1985
A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patientsM Dowsett, A L Harris, R Stuart-Harris, et al.
Pageof 6